Abstract
Organoid culture has been extensively exploited for normal tissue reconstruction and disease modeling. However, it is still challenging to establish organoids that mimic in vivo-like architecture, size and function under homeostatic conditions. Here we describe the development of a long-term adult stem cell-derived mammary mini gland culture system that supports robust three-dimensional outgrowths recapitulating the morphology, scale, cellular context and transcriptional heterogeneity of the normal mammary gland. The self-organization ability of stem cells and the stability of the outgrowths were determined by a coordinated combination of extracellular matrix, environmental signals and dynamic physiological cycles. We show that these mini glands were hormone responsive and could recapitulate the entire postnatal mammary development including puberty, estrus cycle, lactation and involution. We also observed that these mini glands maintained the presence of mammary stem cells and could also recapitulate the fate transition from embryonic bipotency to postnatal unipotency in lineage tracing assays. In addition, upon induction of oncogene expression in the mini glands, we observed tumor initiation in vitro and in vivo in a mouse model. Together, this study provides an experimental system that can support a dynamic miniature mammary gland for the study of physiologically relevant, complex biological processes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Sequencing raw data and counts matrices are available under accession number GEO: GSE211527. Computer code for single-cell transcriptome analysis is available at Supplementary Code. Source data are provided with this paper.
References
Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671–687 (2018).
Hofer, M. & Lutolf, M. P. Engineering organoids. Nat. Rev. Mater. 6, 402–420 (2021).
Fatehullah, A., Tan, S. H. & Barker, N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 18, 246–254 (2016).
Lilja, A. M. et al. Clonal analysis of Notch1-expressing cells reveals the existence of unipotent stem cells that retain long-term plasticity in the embryonic mammary gland. Nat. Cell Biol. 20, 677–687 (2018).
Van Keymeulen, A. et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 479, 189–193 (2011).
Davis, F. M. et al. Single-cell lineage tracing in the mammary gland reveals stochastic clonal dispersion of stem/progenitor cell progeny. Nat. Commun. 7, 13053 (2016).
Jamieson, P. R. et al. Derivation of a robust mouse mammary organoid system for studying tissue dynamics. Development 144, 1065–1071 (2017).
Zhang, L. et al. Establishing estrogen-responsive mouse mammary organoids from single Lgr5+ cells. Cell Signal 29, 41–51 (2017).
Wang, J. et al. Endothelial Wnts control mammary epithelial patterning via fibroblast signaling. Cell Rep. 34, 108897 (2021).
Chu, E. Y. et al. Canonical WNT signaling promotes mammary placode development and is essential for initiation of mammary gland morphogenesis. Development 131, 4819–4829 (2004).
Boras-Granic, K., Dann, P. & Wysolmerski, J. J. Embryonic cells contribute directly to the quiescent stem cell population in the adult mouse mammary gland. Breast Cancer Res. 16, 487 (2014).
Wuidart, A. et al. Early lineage segregation of multipotent embryonic mammary gland progenitors. Nat. Cell Biol. 20, 666–676 (2018).
Stingl, J. et al. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993–997 (2006).
Cai, S. et al. A quiescent Bcl11b high stem cell population is required for maintenance of the mammary gland. Cell Stem Cell 20, 247–260 e245 (2017).
Maller, O., Martinson, H. & Schedin, P. Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland. J. Mammary Gland Biol. Neoplasia 15, 301–318 (2010).
Ghajar, C. M. & Bissell, M. J. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochem. Cell Biol. 130, 1105–1118 (2008).
Nguyen-Ngoc, K. V. & Ewald, A. J. Mammary ductal elongation and myoepithelial migration are regulated by the composition of the extracellular matrix. J. Microsc. 251, 212–223 (2013).
Nguyen-Ngoc, K. V. et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc. Natl Acad. Sci. USA 109, E2595–E2604 (2012).
Nguyen-Ngoc, K. V. et al. 3D culture assays of murine mammary branching morphogenesis and epithelial invasion. Methods Mol. Biol. 1189, 135–162 (2015).
Veltmaat, J. M. et al. Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes. Development 133, 2325–2335 (2006).
Mailleux, A. A. et al. Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development 129, 53–60 (2002).
Zhang, X. et al. FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. Development 141, 3352–3362 (2014).
Ewald, A. J., Brenot, A., Duong, M., Chan, B. S. & Werb, Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev. Cell 14, 570–581 (2008).
Neumann, N. M. et al. Coordination of receptor tyrosine kinase signaling and interfacial tension dynamics drives radial intercalation and tube elongation. Dev. Cell 45, 67–82 e66 (2018).
Kleinberg, D. L., Feldman, M. & Ruan, W. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J. Mammary Gland Biol. Neoplasia 5, 7–17 (2000).
Ki, M. H. et al. All-trans retinoic acid induced differentiation of rat mammary epithelial cells cultured in serum-free medium. Arch. Pharm. Res 21, 298–304 (1998).
Cabezuelo, M. T., Zaragoza, R., Barber, T. & Vina, J. R. Role of vitamin A in mammary gland development and lactation. Nutrients https://doi.org/10.3390/nu12010080 (2019).
McLean, A. C., Valenzuela, N., Fai, S. & Bennett, S. A. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J. Vis. Exp. https://doi.org/10.3791/4389 (2012).
Fata, J. E., Chaudhary, V. & Khokha, R. Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17β-estradiol during the estrous cycle. Biol. Reprod. 65, 680–688 (2001).
Shehata, M. et al. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland. Breast Cancer Res. 14, R134 (2012).
Wiseman, B. S. & Werb, Z. Stromal effects on mammary gland development and breast cancer. Science 296, 1046–1049 (2002).
Mikaelian, I. et al. Expression of terminal differentiation proteins defines stages of mouse mammary gland development. Vet. Pathol. 43, 36–49 (2006).
Asselin-Labat, M. L. et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201–209 (2007).
Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).
Brisken, C. & Rajaram, R. D. Alveolar and lactogenic differentiation. J. Mammary Gland Biol. Neoplasia 11, 239–248 (2006).
Schedin, P., Mitrenga, T. & Kaeck, M. Estrous cycle regulation of mammary epithelial cell proliferation, differentiation, and death in the Sprague–Dawley rat: a model for investigating the role of estrous cycling in mammary carcinogenesis. J. Mammary Gland Biol. Neoplasia 5, 211–225 (2000).
Cai, C. et al. Amphiregulin mediates the hormonal regulation on Rspondin-1 expression in the mammary gland. Dev. Biol. 458, 43–51 (2020).
Macias, H. & Hinck, L. Mammary gland development. Wiley Interdiscip. Rev. Dev. Biol. 1, 533–557 (2012).
Jena, M. K., Jaswal, S., Kumar, S. & Mohanty, A. K. Molecular mechanism of mammary gland involution: an update. Dev. Biol. 445, 145–155 (2019).
Ichinose, R. R. & Nandi, S. Lobuloalveolar differentiation in mouse mammary tissues in vitro. Science 145, 496–497 (1964).
Sumbal, J., Chiche, A., Charifou, E., Koledova, Z. & Li, H. Primary mammary organoid model of lactation and involution. Front. Cell Dev. Biol. 8, 68 (2020).
Nishimori, K. et al. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc. Natl Acad. Sci. USA 93, 11699–11704 (1996).
Kamikawa, A. & Seko, J. Physiological and pharmacological evaluation of oxytocin-induced milk ejection in mice. Exp. Anim. 69, 345–353 (2020).
Marti, A. et al. Mouse mammary gland involution is associated with cytochrome c release and caspase activation. Mech. Dev. 104, 89–98 (2001).
Song, J. et al. Roles of Fas and Fas ligand during mammary gland remodeling. J. Clin. Invest. 106, 1209–1220 (2000).
Ge, Y. & Fuchs, E. Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer. Nat. Rev. Genet. 19, 311–325 (2018).
Rios, A. C., Fu, N. Y., Lindeman, G. J. & Visvader, J. E. In situ identification of bipotent stem cells in the mammary gland. Nature 506, 322–327 (2014).
Centonze, A. et al. Heterotypic cell–cell communication regulates glandular stem cell multipotency. Nature 584, 608–613 (2020).
Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163, 2113–2126 (2003).
Acheampong, T., Kehm, R. D., Terry, M. B., Argov, E. L. & Tehranifar, P. Incidence trends of breast cancer molecular subtypes by age and race/ethnicity in the US from 2010 to 2016. JAMA Netw. Open 3, e2013226 (2020).
Prater, M., Shehata, M., Watson, C. J. & Stingl, J. Enzymatic dissociation, flow cytometric analysis, and culture of normal mouse mammary tissue. Methods Mol. Biol. 946, 395–409 (2013).
Marampon, F. et al. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Mol. Cancer Ther. 8, 543–551 (2009).
Favata, M. F. et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623–18632 (1998).
Allen, L. F., Sebolt-Leopold, J. & Meyer, M. B. CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin. Oncol. 30, 105–116 (2003).
Hayot, C. et al. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol. Appl. Pharmacol. 211, 30–40 (2006).
Shoji, K., Ohashi, K., Sampei, K., Oikawa, M. & Mizuno, K. Cytochalasin D acts as an inhibitor of the actin-cofilin interaction. Biochem. Biophys. Res. Commun. 424, 52–57 (2012).
Nemoto, S., Xiang, J., Huang, S. & Lin, A. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J. Biol. Chem. 273, 16415–16420 (1998).
Maher, P. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation. J. Biol. Chem. 274, 17491–17498 (1999).
TrimGalore v.0.6.7 (GitHub, 2023) https://github.com/FelixKrueger/TrimGalore
FastQC v.0.11.9 (Babraham Institute, 2019) https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 27, 491–499 (2017).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 e3529 (2021).
Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137–1146 (2008).
ELDA: extreme limiting dilution analysis (Walter and Eliza Hall Institute of Medical Research, 2009). http://bioinf.wehi.edu.au/software/elda/
Acknowledgements
We thank the Imaging Facility of Westlake University for assistance in mini gland cleared tissue imaging. We thank the Flow Cytometry Facility of Westlake University for assistance in FACS analysis and sorting. We thank the Westlake Animal Facility for mouse husbandry. This work was supported by National Natural Science Foundation NSF grant 32170803. This work was supported by Westlake Education Foundation.
Author information
Authors and Affiliations
Contributions
L.Y. and S.C. conceived the study and experimental design, performed and analyzed experiments, and wrote the manuscript. S.X. contributed to qRT–PCR, plasmid design and lentivirus production. H.B. and X.L. contributed to single-cell RNA-seq and single-cell RNA-seq analysis. J.L. participated in microscopy analysis. P.C., C.W., S.L., Z.L. and Y.G. assisted with animal experiment.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Methods thanks Cedric Blanpain, Silvia Fre and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editors: Madhura Mukhopadhyay, in collaboration with the Nature Methods team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Optimization of culture conditions for murine mammary gland Organoid.
a, Confocal images of immunostaining of mammary gland at E13.5, E15.5, E17.5 and P1 showing the cellular heterogeneity, polarity and architecture during mammary gland development (top). Model representation of embryonic mammary rudiment formation from E13.5 to birth (bottom). b, Immunofluorescence staining for the indicated markers of organoid. c, Mammary organoid culture for extended time. d, Representative images of organoids cultured for 20d in sphere formation media. e, Bright-field (top and middle rows) and immunofluorescence (bottom row) images of organoids cultured for 3d in the indicated medium, showing the essential factors for symmetry breaking. f, Representative images of organoids cultured for 3d in the indicated inhibitors. g, Representative images (top and middle rows) of organoids cultured for 3d in basic media with/without addition of FGF2 or the indicated inhibitors. Bottom row: Immunofluorescence staining of the frozen section of the organoids. h, Immunofluorescence staining for the indicated markers of the frozen section of the organoids. i, Quantification of Ki67+ cells in mammary organoids under various conditions. n = 3, biological replicates. Data are represented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. j, Motility trajectory plots of individual cells after treatment of indicated factors. X and Y represent spatial coordinates. The unit for X and Y axis is μm. k, Quantification of the speed of movement for the individual cells under indicated treatments. Each panel displays superimposed trajectories of 20 individual cells. n = 3, biological replicates. Data are represented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. l, Time-lapse movie of mammary organoid formation and initiation of symmetry breaking. The red dashed line indicates the formation and healing of the cavity. m, Representative images of organoids cultured in collagen I. n, Representative images of organoid outgrowths in ECM of different ratio of Matrigel and Collagen I. The scale bar represents 500 μm (black) in b, c, d, e, f, g, m, n, 50 μm in a, b, e, g, h (white), l.
Extended Data Fig. 2 Establishment of mini gland culture system.
a, Brightfield images of organoids without feeder cells for 24 days in branching media. b, Immunofluorescence staining of organoid in branching media for indicated markers at d24. c, Representative FACS plots showing mammary cell population from digested organoids without feeder cells. d, Immunofluorescence staining of organoids for indicated markers without feeder cells after pseudo estrus cycles at d20. e, Representative FACS plots showing basal and luminal cell populations from digested organoids without feeder cells after pseudo estrus cycles. f, qRT-PCR analysis of gene expression of mammary gland markers in mammary organoids, compare with primary mammary glands. n = 3, biological replicates. Data are represented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. g, Tracking of the size of the mini gland during one month culture. n = 10, biological replicates. Data are presented as mean ± SEM. h, Immunofluorescence staining for indicated markers from the adult primary mammary gland (left) and mammary mini gland (right). i, Comparison of the TEB widths of the mammary mini-glands and the primary mammary glands. n = 10, biological replicates. Data are presented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. j, Comparison of the duct widths of the mammary mini glands and the primary mammary glands. n = 4, biological replicates. Data are presented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. k, Bright-field images of organoids cultured for 6d in the indicated medium. l, Bright-field images of mini glands cultured in the indicated medium, showing the effect of Fgf10 and Fgf2 in mini gland culture. The scale bar represents 500 μm in a, k, l, 50 μm in b, d, h.
Extended Data Fig. 3 Growth factor requirement of mini gland culture.
a, Representative images of mini gland outgrowths in medium of indicated composition with feeder cells and pseudo estrus cycle. b, Sizes of mini glands tracked from d0 to d14 after seeding in different culture conditions with feeder cells and pseudo estrus cycle. n = 3 biological replicates. c, Representative images of mini gland outgrowths in medium without serum of indicated composition with feeder cells and pseudo estrus cycle. Data are presented as mean ± SEM. The scale bar represents 500 μm in a, c.
Extended Data Fig. 4 Effect of Wnt signaling in mini gland morphogenesis.
a, Schematic diagram showing the introduction of pseudo-estrus cycles into the mammary culture system. b, Representative brightfield images and FACS plots showing mammary cell population from digested organoids without feeder cells. c, Schematic diagram showing the introduction of exogenous Wnt3a (200 ng/ml) and pseudo-estrus cycles into the mammary culture system. d, Representative brightfield images and FACS plots showing mammary cell population from digested organoids without feeder cells but with exogenous Wnt3a. e, Schematic diagram showing the introduction of stromal cells and pseudo-estrus cycles into the mammary culture system. f, Representative brightfield images and FACS plots showing basal and luminal cell populations from digested mini gland. g, Schematic diagram showing the introduction of exogenous Dkk1 (200 ng/ml), stromal cells and pseudo-estrus cycles into the mammary culture system. h, Representative brightfield images and FACS plots showing basal and luminal cell populations from digested mini gland with exogenous Dkk1. i, Comparison of the size of the mammary mini glands under indicated treatments. n = 4, biological replicates. Data are presented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. j, Quantification of the percentage of Sca1−/+ and Cd61-/+ cells in luminal cells. n = 4, biological replicates. Data are represented as mean ± SEM. The scale bar represents 500 μm in b, d, f, h.
Extended Data Fig. 5 Molecular identity of mammary cells in mini gland in vitro.
a, Expression of Cd61 and Sca1 in luminal cells of the mini gland. b, Immunofluorescence staining of mini gland for indicated markers at d26. c, Brightfield images and representative FACS plots showing basal and luminal cell populations from dissociated mini gland. d, qRT-PCR analysis of gene expression of mammary gland markers in the basal-like and luminal-like cells of the mini gland. n = 3 biological replicates. Data are represented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. e, qRT-PCR analysis of gene expression of Sca1- and Sca1+ cell populations from luminal cells in mini gland, compared with primary mammary gland. n = 3, biological replicates. Data are represented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. The scale bar represents 500 μm in c, 50 μm in b.
Extended Data Fig. 6 Characterization of transcriptome of mini gland.
a, UMAP plots comparing the expression of cell identity markers in primary mammary gland epithelial cells and the mini gland. b, UMAP plot comparing the expression of cell identity markers in two basal subpopulations.
Extended Data Fig. 7 Capacity of mini gland undergoing estrus cycle.
a, Multiple pseudo-estrus cycles for mini gland culture. Dashed lines indicate that side branches forming at the primary ducts after estrus cycle. b, Representative images of mini gland outgrowth with or without FGF2 during pseudo estrus cycle. c, Growth curve of mini gland tracked from d0 to d14 with or without FGF2 during pseudo estrus cycle. n = 4 biological replicates. Data are presented as mean ± SEM. d, Transcriptional characterization of the pseudo estrus cycle. n = 3 biological replicates. Data are represented as mean ± SEM. The scale bar represents 500 μm in a, b.
Extended Data Fig. 8 Capacity of mini gland undergoing lactation.
a, Comparison between different lactation strategies. b, Immunofluorescence staining of E-cadherin in mini gland of lactation. White dashed lines indicate the binucleated cells. c, Lipid metabolomics of mini gland and mini gland in lactation. d, Bright-field images of mini gland morphogenesis under lactation induction and involution induction. e, H&E staining of mini gland morphogenesis under lactation induction and involution induction. f, Nile red staining of mini gland morphogenesis under lactation induction and involution induction. g, Immunofluorescence for indicated markers in mini gland under lactation induction and involution induction. h, Bright-field images of mini gland morphogenesis under two round of lactation induction and involution induction. The scale bar represents 500 μm in a, d, h, 50 μm in e, f, g, 10 μm in b.
Extended Data Fig. 9 Exploration of the dynamics of the stem cell fate transition using mini gland.
a, Bright field image of d6 organoids. b, The workflow to analyze the fate of labeled cells after 1d tracing. c, FACS dot plots of luminal cells and basal cells gated within the tdTomato positive and GFP positive populations in Krt14rtTA/TetO-Cre/mTmG organoids with 1day doxycycline induction. Data were collected 1 days after the induction. d, Confocal images of immunostaining of Krt14, Krt8 and GFP in 7d organoids with 1day doxycycline induction. Images showed clonal induction in mammary ducts (arrow). e, qRT-PCR analysis indicating that TNFa level is increased from d2 to d14. mRNA expression was normalized to β-actin; n = 3, Data are presented as mean ± SEM. f, Schematic diagram showing the workflow to study the fate transition with the treatment of TNFa. g, Bright-field image of d14 mini gland with or without the treatment of TNFa. h, Representative FACS dot plots of luminal cells and basal cells gated within the tdTomato positive and GFP positive population in Krt14rtTA/TetO-Cre/mTmG mini gland with the treatment of TNF after doxycycline induction at d6. i, FACS quantification of tdTomato positive and GFP positive basal cell (gray) and luminal cell (black) populations in Krt14rtTA/TetO-Cre/mTmG mini gland after doxycycline induction with TNF treatment; n = 3, Data are presented as mean ± SEM. j, Confocal images of immunostaining of Krt14, Krt8 and GFP in mini gland at d14 with the induction at d6 by 100 ng doxycycline per ml with or without TNF treatment. The staining showed clonal induction in mammary ducts (arrow). k, Schematic diagram showing the workflow to analyze the fate of cells in mini glands labeled at d14 with the treatment of anti-TNF blocking antibody adalimumab. l, Representative FACS dot plots of luminal cells and basal cells gated within the tdTomato positive and GFP positive populations in Krt14rtTA/TetO-Cre/mTmG mini gland after doxycycline induction at d14 and adalimumab treatment for 12 days. m, FACS quantification of tdTomato positive and GFP positive basal cells (gray) and luminal cells (black) after doxycycline induction at d14 with or without the treatment of adalimumab; n = 3, Data are presented as mean ± SEM. n, Confocal images of immunostaining of Krt14, Krt8 and GFP in 26d mini gland induced by 100 ng/ml Doxycycline at d14 with anti-TNF blocking antibody adalimumab treatment. Images showed clonal induction in mammary ducts (arrow). The scale bar represents 500 μm in a, g, 50 μm in d, j, n.
Extended Data Fig. 10 Long-term cultures and in vitro modelling breast cancer using mini gland.
a, Brightfield images of long-term culture of organoid without feeder cells. Organoid collapsed and formed many vacuolar structures (arrow). b, Percentage of well-maintained organoids over time, cultured without feeder cells. c, Representative FACS plots showing basal and luminal cell populations from 117d mini gland. d, Sphere formation from flow cytometry-sorted basal and luminal cells of the 117d mini gland. e, Brightfield images of the development of a mini gland into a branching structure. f, 293T cell lines were infected with mCherry-LSL-PyMT-GFP virus, and then with or without transient transfected Cre plasmid. g, qRT-PCR analysis of PyMT expression with or without transient transfection of Cre plasmid. n = 3, biological replicates. Data are represented as mean ± SEM. P values were calculated using two-sided unpaired Student’s t-test. h, Confocal images of immunostaining of Krt8 and GFP in d38 mini gland with a tumor-like structure and control cells with mock vector (without PyMT). i, Representative FACS dot plots, H&E staining, and confocal images of immunostaining of Krt14, Krt5, Krt8 and Ki67 in spontaneous mouse model of MMTV-PyMT. j, k, Representative H&E staining, and confocal images of immunostaining of Krt14, Krt5, Krt8 and Ki67 in d38 mini gland with a tumor-like structure. The scale bar represents 500 μm in a, d, e, 200um in f, 50 μm in h, i, j, k.
Supplementary information
Supplementary Information
The supplementary information for an example of the FACS gating strategy.
Supplementary Table 1
Summary of the experimental procedures.
Supplementary Table 2
Comparison with previous research of generation of mammary gland organoids versus our work.
Supplementary Table 3
Primers for qPCR.
Supplementary Video 1
Time-lapse movie of mammary organoid formation and initiation of symmetry breaking.
Supplementary Code
Supplementary code.
Source data
Source Data Fig. 1
Image source data, statistical source data.
Source Data Fig. 2
Image source data, statistical source data.
Source Data Fig. 3
Image source data.
Source Data Fig. 4
Image source data.
Source Data Fig. 5
Image source data, statistical source data.
Source Data Fig. 6
Image source data.
Source Data Extended Data Fig. 1
Image source data, statistical source data.
Source Data Extended Data Fig. 2
Image source data, statistical source data.
Source Data Extended Data Fig. 3
Image source data, statistical source data.
Source Data Extended Data Fig. 4
Image source data, statistical source data.
Source Data Extended Data Fig. 5
Image source data, statistical source data.
Source Data Extended Data Fig. 7
Image source data, statistical source data.
Source Data Extended Data Fig. 8
Image source data, statistical source data.
Source Data Extended Data Fig. 9
Image source data, statistical source data.
Source Data Extended Data Fig. 10
Image source data, statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yuan, L., Xie, S., Bai, H. et al. Reconstruction of dynamic mammary mini gland in vitro for normal physiology and oncogenesis. Nat Methods 20, 2021–2033 (2023). https://doi.org/10.1038/s41592-023-02039-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41592-023-02039-y
This article is cited by
-
Year in review 2023
Nature Methods (2024)
-
A dynamic culture system that models the intricacy of the mammary gland
Nature Reviews Molecular Cell Biology (2024)
-
Closing in on cancer heterogeneity with organoids
Nature Methods (2024)
-
Using Organoids to Tap Mammary Gland Diversity for Novel Insight
Journal of Mammary Gland Biology and Neoplasia (2024)
-
Modeling the complexity of mammary gland in vitro
Nature Methods (2023)